Skip to main content
. 2021 Apr 26;16(4):e0250673. doi: 10.1371/journal.pone.0250673

Table 3. Summary of evidence for repositioning error.

Outcome Comparisons Relative effect (95%CI) Patients /controls (studies) Quality of evidence (GRADE) Evidence and significance
Average estimate in NSLBP group Average estimate in control group
Absolute error NSLBP: Control: SMD 0.705 460/228 ⊕◯◯◯ Very low-level evidence of greater (medium effect) AE in NSLBP patients than in asymptomatic individuals
Very low1,2,3
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [0.199, 1.212] Statistically significant difference (11)
All studies
Absolute error NSLBP: Control: SMD 0.651 405/183 ⊕◯◯◯ Very low-level evidence of no difference in AE between NSLBP patients and asymptomatic individuals
Pooled weighted mean±SD was 4.6±3.2° (mean range 0.9 to 10.6) Pooled weighted mean±SD was 1.8±2.0° (mean range 0.7 to 4.47) [0.000, 1.302] Statistically significant difference (8) Very low1,2,3
Studies reporting AE in degrees
Absolute error NSLBP: Control: SMD 0.720 432/200 ⊕◯◯◯ Very low-level evidence of greater (medium effect) AE in NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [0.160, 1.281] Statistically significant difference (10) Very low1,2,3
(adults only)
Absolute error Mild-NSLBP: Control: SMD 0.525 134/87 ⊕⊕◯◯ Moderate level evidence of greater (small effect) AE in patients with mild NSLBP than in asymptomatic individuals
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [0.037, 1.013] Statistically significant difference (4) Low2,3
Mild NSLBP
Absolute error Moderate-NSLBP: Pooled weighted mean±SD not estimable* Control: SMD 0.725 301/162 ⊕◯◯◯ Very low-level evidence of greater (medium effect) AE in patients with moderate to severe NSLBP than in asymptomatic individuals
Pooled weighted mean±SD not estimable* [0.007, 1.443] Statistically significant difference (7) Very low1,2,3
Moderate to severe NSLBP
Absolute error FP-NSLBP: Control: SMD 1.219 160/136 ⊕◯◯◯ Very low-level evidence of greater (large effect) AE in FP subgroup of NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [0.719, 1.719] Statistically significant difference (6) Very low1,2,3
FP NSLBP subgroup
Absolute error FP-NSLBP: Control: SMD 1.287a 130/106 ⊕◯◯◯ Very low-level evidence of greater (large effect) AE in FP subgroup of NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD was 7.1±3.9° (mean range 4.6 to 7.9) Pooled weighted mean±SD was 2.3±1.1° (mean range 0.7 to 4.47) [0.595, 1.980] Statistically significant difference (4) Very low1,2,3
FP NSLBP subgroup (error in degrees)
Absolute error FP-NSLBP: Control: SMD 1.289 145/108 ⊕⊕◯◯ Low level evidence of greater (large effect) AE in FP adult subgroup of NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [0.719, 1.859] Statistically significant difference (5) Low2,3
FP NSLBP subgroup (adults)
Absolute error AEP-NSLBP: Pooled weighted mean±SD was 6.3±3.2° (mean range 3.4 to 7.6) Control: SMD 1.486b 75/91 ⊕◯◯◯ Very low-level evidence of greater (large effect) AE in AEP subgroup of NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD was 2.2±0.9° (mean range 1.8 to 3.1) [0.239, 2.732] Statistically significant difference (3) Very low1,2,3
AEP NSLBP subgroup
Absolute error AEP-NSLBP: Control: SMD 2.080c 62/63 ⊕⊕⊕◯ Moderate level evidence of greater (very large effect) AE in AEP adult subgroup of NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD was 6.9±3.5° (mean range 5.7 to 7.6) Pooled weighted mean±SD was 1.8±0.8° (mean range 1.8 to 1.8) [1.574, 2.585] Statistically significant difference (2) Moderate3
AEP NSLBP subgroup (adults)
Absolute error NSLBP: Control: SMD 0.876 277/152 ⊕◯◯◯ Very low-level evidence of greater (medium effect) AE in blindfolded NSLBP patients than in asymptomatic individuals
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [0.231, 1.521] Statistically significant difference (7) Very low1,2,3
Vision obscured
Absolute error NSLBP: Control: SMD 0.325 198/91 ⊕◯◯◯ Very low-level evidence of no difference in AE between NSLBP patients and asymptomatic individuals with vision available
Pooled weighted mean±SD not estimable* Pooled weighted mean±SD not estimable* [-0.075, 0.725] Non-statistically significant difference (5) Very low1,2,3
Vision available
Absolute error NSLBP: Control: SMD 0.665 102/306 ⊕◯◯◯ Very low-level evidence of no difference in transverse plane AE between NSLBP patients and asymptomatic individuals
Pooled weighted mean±SD was 2.7±0.5° (mean range 1.6 to 4.4) Pooled weighted mean±SD was 2.5±0.7° (mean range 1.6 to 3.6) [-0.495, 1.825] Non-statistically significant difference (3) Very low1,2,3
Transverse plane

1 Downgraded due to indirectness.

2 Downgraded due to inconsistency.

3 Downgraded due to imprecision.

* Pooled weighted mean not estimable as included studies did not report AE, VE, or CE as an angular measure, or did not report values for mean±SD.

a Pooled weighted SD was 2.64° resulting in an effect estimate of 3.4°—non-clinically significant.

b Pooled weighted SD was 1.94° resulting in an effect estimate of 2.9°—non-clinically significant.

c Pooled weighted SD was 2.1° resulting in an effect estimate of 4.4°—non-clinically significant.

Abbreviations: SMD, standardized mean difference, CI, confidence intervals; NSLBP, non-specific low back pain; SD, standard deviation; AE, absolute error; NSLBP, non-specific low back pain; FP, flexion pattern; AEP, active extension pattern.